Abstract
We examined the combined effect of radiation and BOF-A2, a newly developed anti-cancer agent consisting of a masked form of 5-fluorouracil (5-FU) and a potent inhibitor of 5-FU degradation in the liver, on murine tumors. Subcutaneous 8-mm-diameter SCCVII tumours grown in the right thigh of C3H/He mice were used. The mice were locally irradiated with single doses of 10-30 Gy or five fractions of 4 Gy for 5 days, alone or in combination with BOF-A2. BOF-A2 at doses of 30, 75 and 150 mg kg-1 was orally administered 2 h before or immediately after single doses of irradiation, while 15 or 30 mg kg-1 of BOF-A2 was given 1 h prior to each fraction of 4 Gy. The effect of BOF-A2 alone was also examined. The antitumour effect was evaluated by a tumour growth delay assay. BOF-A2 alone showed significant tumour growth delay at all doses used in this study. Combination of BOF-A2 and single or fractionated doses of radiation appeared to produce an additive tumour response, which occurred independently of sequence of the two treatments. The combined effect became greater with the dose of radiation and BOF-A2. In conclusion, BOF-A2 and radiation may be efficiently combined.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Byfield J. E., Calabro-Jones P., Klisak I., Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays. Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):1923–1933. doi: 10.1016/0360-3016(82)90451-5. [DOI] [PubMed] [Google Scholar]
- CHAUDHURI N. K., MONTAG B. J., HEIDELBERGER C. Studies on fluorinated pyrimidines. III. The metabolism of 5-fluorouracil-2-C14 and 5-fluoroorotic-2-C14 acid in vivo. Cancer Res. 1958 Apr;18(3):318–328. [PubMed] [Google Scholar]
- Fujii S., Fukushima M., Shimamoto Y., Ohshimo H., Imaoka T., Shirasaka T. Antitumor activity of BOF-A2, a new 5-fluorouracil derivative. Jpn J Cancer Res. 1989 Feb;80(2):173–181. doi: 10.1111/j.1349-7006.1989.tb02286.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lokich J. J. Optimal schedule for 5-fluorouracil chemotherapy. Intermittent bolus or continuous infusion? Am J Clin Oncol. 1985 Oct;8(5):445–448. [PubMed] [Google Scholar]
- Maehara Y., Nagayama S., Okazaki H., Nakamura H., Shirasaka T., Fujii S. Metabolism of 5-fluorouracil in various human normal and tumor tissues. Gan. 1981 Dec;72(6):824–827. [PubMed] [Google Scholar]
- Miyauchi S., Imaoka T., Utsunomiya T., Hayashi K., Kubo M., Kawaguchi T., Matsui Y. Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels. Jpn J Cancer Res. 1994 Jun;85(6):665–668. doi: 10.1111/j.1349-7006.1994.tb02411.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Okayasu T., Sugiyama K., Miyauchi S. Inhibition of catabolic pathway of 5-fluorouracil by 3-cyano-2,6-dihydroxypyridine in human lung cancer tissues. Jpn J Cancer Res. 1994 Jan;85(1):101–105. doi: 10.1111/j.1349-7006.1994.tb02892.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shibamoto Y., Sasai K., Abe M. The radiation response of SCCVII tumor cells in C3H/He mice varies with the irradiation conditions. Radiat Res. 1987 Feb;109(2):352–354. [PubMed] [Google Scholar]
- Shibamoto Y., Yukawa Y., Tsutsui K., Takahashi M., Abe M. Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J Cancer Res. 1986 Sep;77(9):908–915. [PubMed] [Google Scholar]
- Tatsumi K., Yamauchi T., Kiyono K., Kishi K., Yanagihara Y., Imaoka T., Kawaguchi T., Kubo M. 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase. J Biochem. 1993 Dec;114(6):912–918. doi: 10.1093/oxfordjournals.jbchem.a124276. [DOI] [PubMed] [Google Scholar]
- Weinberg M. J., Rauth A. M. 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 1987 Nov;13(11):1691–1699. doi: 10.1016/0360-3016(87)90166-0. [DOI] [PubMed] [Google Scholar]
